Hayashi Masami

2019 - 2023 Analysis of extracellular vesicles using patient derived xenograft

2019 - 2023 複合的癌免疫治療による子宮頚癌治療の革新的開発

2018 - 2021 Target therapy of ovarian cancer including immunotherapy via Eribulin

2017 - 2020 Treatment strategy of boron neutron capture therapy in cervical cancer

2017 - 2020 Development of a new therapy for refractory ovarian cancer via liposomal nanoparticle targeting control of EMT

2017 - 2020 Research for cancer microenvironment via FABP4 in endometrial cnacer

2016 - 2019 Analysis of lipid raft via CD24 and drug resistance in gynecologic cancer

2016 - 2019 A novel approach for cervical cancer using exosome

2016 - 2019 activation regulatory mechanism of cancer fibroblast by obesity

2016 - 2019 A novel miRNA regulates the EMT and MMT of peritoneal mesothelium in ovarian cancer

2016 - 2019 The New therapy of placental insufficiency ~ Endothelial progenitor cells for angiojenesis and new anticoagulant therapy

2015 - 2018 GPR30 signaling regulates Epithelial-Mesenchymal Transition in ovarian cancer

2015 - 2018 Testosterone for the Prevention of Cyclophosphamide -Induced Ovarian Toxicity

2013 - 2016 Development of anticancer drug resistance evaluation system, and early recurrence-detection tools in ovarian cancer

2013 - 2016 CD24-targeting drug delivery system enhanced effect of cisplatin-resistant ovarian cancer cells

2013 - 2016 Potential therapeutic target of microRNA in cervical cancer.

2012 - 2015 Control of EMT phenomenon by mTOR inhiibitor for ovarian clear cell carcinoma.

2012 - 2015 Fibrates protect against vascular endothelial dysfunction induced by paclitaxel and carboplatin chemotherapy for cancer patients: a pilot study.

2012 - 2015 To control in invasion and metastasis through EMT (Epithelial-Mesenchymal-Transition) functional analysis of CD24 in endometrial cancer

2011 - 2012 子宮頸癌に対するC-myc結合蛋白を標的とした分子標的治療の可能性の検討

2009 - 2010 Analysis of anticancer drug-resistant ovarian cancer cells under hypoxic tumor microenvironment